about
Weighted change-point method for detecting differential gene expression in breast cancer microarray dataEpigenetic modifications and diabetic retinopathyDifferential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatinStructure of the α-tubulin acetyltransferase, αTAT1, and implications for tubulin-specific acetylationA transcriptional repressor co-regulatory network governing androgen response in prostate cancersTranscriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1Histone deacetylase inhibitors: Potential in cancer therapyMethylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesisHistone H4 lysine 16 acetylation regulates cellular lifespanClinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitorEpigenetic regulators and their impact on therapy in acute myeloid leukemiaPotential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune TherapyHDAC8 substrates: Histones and beyondTranscriptional control of cancer metastasisTrials with 'epigenetic' drugs: an updateCustomized targeted therapy in Hodgkin lymphoma: hype or hope?New and emerging HDAC inhibitors for cancer treatmentHDAC activity is required during Xenopus tail regenerationEffectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cellsStructural, kinetic and proteomic characterization of acetyl phosphate-dependent bacterial protein acetylationEpigenetics in Intestinal Epithelial Cell RenewalEpigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Environmental chemical exposures and human epigeneticsEpigenetic regulation of a murine retrotransposon by a dual histone modification markHuman cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNAVorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanismsInhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancerTFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like responseCytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular CarcinomaLSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16ATP-citrate lyase links cellular metabolism to histone acetylationEntrapment of a Histone Tail by a DNA Lesion in a Nucleosome Suggests the Lesion Impacts Epigenetic Marking: A Molecular Dynamics Study.Nucleosome Histone Tail Conformation and Dynamics: Impacts of Lysine Acetylation and a Nearby Minor Groove Benzo[a]pyrene-Derived LesionQuantification of Lysine Acetylation and Succinylation Stoichiometry in Proteins Using Mass Spectrometric Data-Independent Acquisitions (SWATH)Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors.SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer.Activation of the unfolded protein response contributes toward the antitumor activity of vorinostat.Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA).Crosstalk between the DNA damage response, histone modifications and neovascularisation.
P2860
Q21134908-1BBC5B8D-CF68-4285-9EA8-A83BA80AD594Q21284810-431DD99E-B13C-47C2-BE1D-1B1DE35C8631Q24293063-36800B21-6ECE-4569-93CC-930CA6DA3B1EQ24300995-73C04D70-8C4D-47C2-8BB7-4A5A7D91E571Q24317244-A69666A4-3AF2-416D-BD44-78374D1B8FD1Q24324150-D82A0076-BE76-4DE2-BF3F-9734716EEE48Q24649025-0AC44A0B-8D4E-4C60-9655-027CF03E8FC6Q24656948-15263F52-2523-4C13-A0C6-F199312C1D63Q24657553-68D9D646-DC9E-4BF0-96A0-2ED8AFEEECCFQ26747768-8526101A-CAB6-4F2C-88B0-A48EF0999C06Q26765402-1F6BD4D9-B087-4FAB-8D71-7011D906D6A4Q26771601-5B337FC2-EF6A-4FC5-B211-747549929D54Q26783032-55674983-DF92-4FE1-AAAD-BAB17F30CF2CQ26824122-58FAF74B-164A-49D6-AB5F-14D6188B8E58Q26992024-98EA6C32-A36C-414A-9E11-C3B513DB29FEQ27000542-345906D4-F17D-4E96-87F9-C0E06C44351FQ27002554-B15DFAEB-C137-4919-AA6B-B3680EDB032FQ27022413-78F225F1-58A1-4198-BE68-C30CF442BFD4Q27316244-9A192611-3CE4-451C-88B1-C0EDE3882254Q27335252-0B52CEB0-2B43-49F9-B38E-6E791D2CECE3Q27683517-2CFF21DD-FA70-4CA7-A308-9E6FDBBE76CBQ28071369-6660B2A1-1EA9-4983-A01E-C9F83A12C466Q28076548-FFBD433A-FFC2-4FCD-9CD9-2DE43F32559FQ28397621-73FF8F37-7740-4A23-80FC-4D4A39E3AE10Q28473811-73ECDEEA-0C53-49B9-9804-E2E3FA821247Q28474716-CFEBBCA1-643C-4FB8-B485-BD452CDE5D29Q28484904-DE76A5FC-5A17-4435-8C5A-B5CC90B9328FQ28488474-D14B61A1-6108-4B40-9ED1-85182B5E1209Q28539226-8C9A0D31-70EC-4A02-A18C-5C9A4B09124BQ28551435-44186342-234F-444D-A7C2-5A9272ADB0F8Q28593421-AA436102-1EBB-472A-83BE-0C0779A30536Q29615367-993835C8-7E7B-4272-8B9B-3B9F9789C84DQ30699828-345E5EB0-56C0-4B60-8D0C-1F2887C1DEBAQ30855026-E1FC4231-36F1-4D77-B128-6BFDE3E1EF03Q31126463-70DC9288-2291-40F7-9C83-A5747C2BA7D3Q33390876-7B70DAA2-B165-4ED5-93EE-5DFF04E91E99Q33588169-D44C1660-BE67-4B5D-8838-2AA7DD081D8DQ33588300-930A72F5-8B86-4CA6-B152-25A6EFFE282DQ33590788-11541B86-8F7D-4904-9B4A-17D6D3128340Q33639330-8E660194-D881-44AC-B6F9-02BBEFA50235
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Histone deacetylases and cancer
@ast
Histone deacetylases and cancer
@en
Histone deacetylases and cancer
@nl
type
label
Histone deacetylases and cancer
@ast
Histone deacetylases and cancer
@en
Histone deacetylases and cancer
@nl
prefLabel
Histone deacetylases and cancer
@ast
Histone deacetylases and cancer
@en
Histone deacetylases and cancer
@nl
P2860
P3181
P356
P1433
P1476
Histone deacetylases and cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1210610
P407
P577
2007-08-13T00:00:00Z
P5875
P6179
1023418889